Cambridge-based synthetic biology company developing advanced microbial expression platforms for the production of complex proteins and other high-value biological molecules. The company combines a proprietary library of diverse, unconventional microorganisms with artificial intelligence and machine learning to identify the optimal host system for manufacturing proteins that are difficult or impossible to produce using conventional expression technologies. By enabling improved protein folding, post-translational modifications, stability, and yield, HERlab aims to accelerate innovation across biopharmaceuticals, cellular agriculture, biomaterials, and industrial biotechnology. Through its novel bioproduction platform, the company is helping unlock new possibilities for the scalable and sustainable manufacture of next-generation biological products.